Coronavirus Disease - 2019 (COVID-19) and Supply of Substances of Human Origin in EU/EEA - First Update   [open pdf - 0B]

From the Scope of the Document: "This first update of the original document is prompted by the recent scientific developments and evolution of the coronavirus 2019 (COVID-19) pandemic and the need to include types of substances of human origin (SoHO) that were not addressed in the first version (e.g. reproductive and some non-reproductive tissues and cells). The document aims to provide a risk assessment and management options for the safe and sustainable supply of SoHO to assist the European Union and European Economic Area (EU/EEA) Member States in responding to the threat posed by the COVID-19 pandemic. Following the rapid spread of COVID-19 in the EU/EEA and worldwide, the European Centre for Disease Prevention and Control (ECDC) has been publishing rapid risk assessments and setting out measures on how to maintain the safety and sustainability of SoHO supply. These documents have also advocated the activation of pandemic plans to prepare for large outbreaks and community transmission of COVID-19. The first version of this document and the current update also consider the current evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARSCoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV), and seasonal or pandemic influenza viruses. ECDC will update the document as and when new relevant information becomes available, or as required by the epidemiological situation."

2020 European Centre for Disease Prevention and Control
Retrieved From:
European Centre for Disease Prevention and Control: https://www.ecdc.europa.eu/
Media Type:
Help with citations